Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-19-001993
Filing Date
2019-01-04
Accepted
2019-01-04 16:34:03
Documents
1
Period of Report
2019-01-02

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3872
  Complete submission text file 0001209191-19-001993.txt   5275
Mailing Address 1119 ST. PAUL STREET BALTIMORE MD 21202
Business Address
MOTT DAVID M (Reporting) CIK: 0001219871 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38129 | Film No.: 19510540

Mailing Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139 617-498-0020
Mersana Therapeutics, Inc. (Issuer) CIK: 0001442836 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations